Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inotiv, Inc.
  6. Company
    NOTV   US45783Q1004

INOTIV, INC.

(NOTV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Inotiv, Inc.
Inotiv, Inc, formerly Bioanalytical systems, Inc., is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: research services and research products. The research services segment provides research and development support on a contract basis directly to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. The Company supports both the non-clinical and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, but also including biotherapeutics and devices.

Number of employees : 421 people.
Sales per Business
20192020Delta
Services39.0589.5%57.1894.6% +46.43%
Products4.5710.5%3.295.4% -27.93%
USD in Million
Sales per region
20192020Delta
United States39.6390.9%56.2593% +41.93%
Pacific Rim2.415.5%2.834.7% +17.41%
Europe1.222.8%1.212% -0.82%
Other North America0.220.5%0.150.2% -32.11%
Other0.140.3%0.040.1% -75%
USD in Million
Managers
Name Title Age Since
Robert Leasure President, Chief Executive Officer & Director 60 2019
Beth A. Taylor Chief Financial Officer, Secretary & VP-Finance 54 2020
John Gregory Beattie Chief Operating Officer 53 2021
Richard Allen Johnson, Dr. Independent Director 74 2012
Gregory C. Davis, Dr. Chairman 66 2017
R. Matthew Neff Independent Director 64 2017
John E. Sagartz, Dr. Independent Director & Chief Strategy Officer 55 2018
Kimberly Beaty Senior Director-Marketing - -
Candace A. Rohde Johnson Director-InVivo Products & Services - 2017
Philip A. Downing Senior Vice President-Preclinical Services - 2019
Members of the board
Name Title Age Since
Gregory C. Davis, Dr. Chairman 66 2017
Richard Allen Johnson, Dr. Independent Director 74 2012
R. Matthew Neff Independent Director 64 2017
John E. Sagartz, Dr. Independent Director & Chief Strategy Officer 55 2018
Robert Leasure President, Chief Executive Officer & Director 60 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,827,839 9,857,969 62.3% 0 0.0% 62.3%
Stock B 0 25 0 0.0% 0 0.0%
Shareholders
NameEquities%
Peter T. Kissinger 1,285,767 8.12%
Phillip Bendele 837,639 5.29%
Renaissance Technologies LLC 681,165 4.30%
John E. Sagartz 648,524 4.10%
estate of Hamot Seth W 636,621 4.02%
Kimberly L Sagartz 634,759 4.01%
Next Century Growth Investors LLC 625,016 3.95%
The Vanguard Group, Inc. 371,461 2.35%
Healthinvest Partners AB 320,234 2.02%
IsZo Capital Management LP 313,522 1.98%
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
INOTIV, INC.0.00%465
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.46%31 265
SEAGEN INC.-18.34%25 955
CUREVAC N.V.-33.14%21 497
PHARMARON BEIJING CO., LTD.52.44%21 355
ALNYLAM PHARMACEUTICALS, INC.37.04%20 936
HANGZHOU TIGERMED CONSULTING CO., LTD-5.39%20 084
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.57.40%19 763
BIO-TECHNE CORPORATION48.68%18 362
INCYTE CORPORATION-8.83%16 993
PPD, INC.34.42%16 155
NOVAVAX, INC.73.40%14 324
QIAGEN N.V.-3.05%11 704
ICON PUBLIC LIMITED COMPANY10.78%11 446
PRA HEALTH SCIENCES, INC.0.00%10 965
INTELLIA THERAPEUTICS, INC.146.32%9 735
CRISPR THERAPEUTICS AG-22.13%9 553
SYNEOS HEALTH, INC.28.06%9 015